Skip to main content
. 2018 Sep 12;35(10):1564–1577. doi: 10.1007/s12325-018-0784-z

Fig. 2.

Fig. 2

Treatment sequences. The inner cycle depicts the 1L treatment; the outer cycle depicts the 2L treatment. nab-P + G, nanoparticle albumin-bound paclitaxel/gemcitabine; FFX, FOLFIRINOX; 5-FU based w/Nal-IRI, fluorouracil (5-FU) based regimen with nanoliposomal irinotecan; 5-FU based w/o Nal-IRI, fluorouracil (5-FU) based regimen without nanoliposomal irinotecan; G based w/ABR, gemcitabine-based regimen with nanoparticle albumin-bound paclitaxel; G based w/o ABR, gemcitabine-based regimen without nanoparticle albumin-bound paclitaxel; Hospice or SC only, hospice or supportive care only; Other, other drug (active) treatment; 1L, first-line